» Articles » PMID: 17602286

Multifaceted Roles of Integrins in Breast Cancer Metastasis

Overview
Date 2007 Jul 3
PMID 17602286
Citations 42
Authors
Affiliations
Soon will be listed here.
Abstract

Malignant breast cancer can be a debilitating disease due to metastasis to tissues such as brain or bone. The metastatic process involves the invasion of tumor cells into the adjacent tissue, followed by systemic dissemination and colonization of secondary organs. These processes require interactions between tumor cells and a changing microenvironment, which drive cell proliferation, migration, invasion and colonization, as well as promoting cell survival. The integrin family of cell adhesion receptors has been shown to play a critical role in all of these processes, consistent with their extracellular matrix binding properties. Experiments in cultured epithelial cells and in vivo models have demonstrated that integrins can promote various stages of metastasis by modulating the effects of growth factor receptors, extracellular proteases and chemotactic molecules. Integrins may therefore play a pivotal role in multiple mechanisms of metastasis. As a result, they represent promising targets for effective treatment of metastatic breast cancer.

Citing Articles

Navigating challenges: optimising methods for primary cell culture isolation.

Piwocka O, Musielak M, Ampula K, Piotrowski I, Adamczyk B, Fundowicz M Cancer Cell Int. 2024; 24(1):28.

PMID: 38212739 PMC: 10785493. DOI: 10.1186/s12935-023-03190-4.


Low Expression of TSTD2 Serves as a Biomarker for Poor Prognosis in Kidney Renal Clear Cell Carcinoma.

Tang G, Sun K, Ding G, Wu J Int J Gen Med. 2023; 16:1437-1453.

PMID: 37114071 PMC: 10126726. DOI: 10.2147/IJGM.S408854.


Time-extended exposure of gastric epithelial cells to secretome of -activated fibroblasts induces reprogramming of gastric epithelium towards pre-cancerogenic and pro-invasive phenotype.

Krzysiek-Maczka G, Targosz A, Wrobel T, Paw M, Szczyrk U, Opila J Am J Cancer Res. 2022; 12(3):1337-1371.

PMID: 35411238 PMC: 8984895.


Pharmacological Effects and Underlying Mechanisms of Licorice-Derived Flavonoids.

Wu Y, Wang Z, Du Q, Zhu Z, Chen T, Xue Y Evid Based Complement Alternat Med. 2022; 2022:9523071.

PMID: 35082907 PMC: 8786487. DOI: 10.1155/2022/9523071.


A Complex and Evolutive Character: Two Face Aspects of ECM in Tumor Progression.

Sala M, Ros M, Saltel F Front Oncol. 2020; 10:1620.

PMID: 32984031 PMC: 7485352. DOI: 10.3389/fonc.2020.01620.


References
1.
Aguirre-Ghiso J . The problem of cancer dormancy: understanding the basic mechanisms and identifying therapeutic opportunities. Cell Cycle. 2006; 5(16):1740-3. PMC: 2587296. DOI: 10.4161/cc.5.16.3165. View

2.
Karrison T, Ferguson D, Meier P . Dormancy of mammary carcinoma after mastectomy. J Natl Cancer Inst. 1999; 91(1):80-5. DOI: 10.1093/jnci/91.1.80. View

3.
Ellis V, Pyke C, Eriksen J, Solberg H, Dano K . The urokinase receptor: involvement in cell surface proteolysis and cancer invasion. Ann N Y Acad Sci. 1992; 667:13-31. DOI: 10.1111/j.1749-6632.1992.tb51591.x. View

4.
Hofmann U, Westphal J, van Kraats A, Ruiter D, van Muijen G . Expression of integrin alpha(v)beta(3) correlates with activation of membrane-type matrix metalloproteinase-1 (MT1-MMP) and matrix metalloproteinase-2 (MMP-2) in human melanoma cells in vitro and in vivo. Int J Cancer. 2000; 87(1):12-9. DOI: 10.1002/1097-0215(20000701)87:1<12::aid-ijc3>3.0.co;2-a. View

5.
Tuck A, Arsenault D, OMalley F, Hota C, Ling M, Wilson S . Osteopontin induces increased invasiveness and plasminogen activator expression of human mammary epithelial cells. Oncogene. 1999; 18(29):4237-46. DOI: 10.1038/sj.onc.1202799. View